advertisement
advertisement
advertisement
  • 01.12.17

CVS is coming out with a much cheaper generic version of EpiPen

CVS said today it’s planning to sell a generic EpiPen competitor at a fraction of the price. Under pressure from lawmakers and the public last year, Mylan announced a generic version of the life-saving auto-injector at a list price of $300. CVS Health says its version will sell for only $110. That’s down significantly from the $600 Mylan had been charging. USA Today has more about the announcement.